ISOTRETINOIN Mepha caps moll 5 mg 30 pce
7680559720012
CH-55972
D10BA01
10.02.0.
Reimbursement limitations:
TRETINAC
Formes graves de l'acné, résistantes à la thérapie.
1 / 3
google
Details
- Product number
- 5597204
- CPT
- -
- Packaging group
- 30
- Unit
- Kapsel(n)
- Composition
- isotretinoinum 5 mg, sojae oleum raffinatum 66.4 mg, int-rac-alpha-tocopherolum, dinatrii edetas corresp. natrium 0.03 mg, E 320, sojae oleum partim hydrogenatum 3.85 mg, oleum vegetabile hydrogenatum, cera flava, Kapselhülle: gelatina, glycerolum, sorbitolum liquidum non cristallisabile 5 mg, aqua purificata, E 171, pro capsula.
Articles (1)
Isotretinoin-Mepha 5mg, Weichkapseln
Weichkapseln
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
66.4 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.03 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | ANTOX |
|
(N/A)
|
3.85 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
5.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
Reimbursement information
Public price
CHF 15.95
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/07/2018
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 55972
- Drug name
- Isotretinoin-Mepha, Weichkapseln
- Galenic form
- KAPWE
- ATC Code
- D10BA01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 18/09/2002
- Authorization expiration date
- 31/12/9999
- IT number
- 10.02.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ISOTRETINOIN Mepha caps moll 5 mg 30 pce
- Description (DE)
- ISOTRETINOIN Mepha Weichkaps 5 mg 30 Stk
- Market launch
- 21/03/2018
- Narcotic (BTM)
- No